EISAI'S Lenvima (lenvatinib), an Australian researched therapy for people living with progressive, locally advanced or metastatic differentiated thyroid cancer, is PBS listed from today.
Visit eisai.com.au to source the PI.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Dec 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Dec 16